EOLS- Evolus, Inc.
Evolus, Inc. (EOLS) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. EOLS is classified in the Pharmaceuticals industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 604.7K | $4.48M | - | |
| Other | 427.4K | $3.17M | - | |
| Dir | 321.1K | $2.38M | - | |
| CFO | 226.1K | $1.68M | - | |
| Dir | 134.2K | $994.3K | - |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Beaver Sandra67 | Chief Financial Officer | Sell | 3,276 | $14.98 | $49,074.48 | -2.2% | -13.7% | -47.9% | |
| Aug 30, 2024 | Yamagishi-Dressler Tomoko74 | Chief Marketing Officer | Sell | 5,631 | $15.85 | $89,251.35 | -6.4% | -13.8% | -52.0% | |
| Jun 6, 2024 | Moatazedi David67 | See Remarks | Sale+OE | 471,432 | $12.74 | $6,005,627.99 | -22.8% | +24.3% | -19.0% | |
| Jun 3, 2024 | Malik Vikram54 | Director | Sell | 7,500 | $12.96 | $97,203.00 | -3.0% | +19.8% | -23.4% | |
| May 14, 2024 | Gill David N | Director | Sell | 10,361 | $12.64 | $131,009.60 | -12.2% | +2.2% | -21.8% | |
| May 13, 2024 | Malik Vikram54 | Director | Sell | 28,000 | $12.93 | $362,012.00 | -9.9% | +3.5% | -19.7% | |
| May 10, 2024 | Avelar Rui68 | See Remarks | Sell | 3,441 | $12.72 | $43,760.57 | -0.9% | +2.2% | -23.1% | |
| May 10, 2024 | Moatazedi David67 | See Remarks | Sell | 16,051 | $12.72 | $204,126.99 | -2.3% | +2.2% | -23.1% | |
| May 10, 2024 | Beaver Sandra67 | Chief Financial Officer | Sell | 2,423 | $12.72 | $30,814.26 | -1.6% | +2.2% | -23.1% | |
| Mar 27, 2024 | Moatazedi David67 | See Remarks | Sell | 6,236 | $13.86 | $86,430.96 | -0.9% | -25.4% | -12.6% |